42 completed, 21 unknown, 10 not yet recruiting, 10 recruiting. 20 Not applicable, 10 Phase 2, 8 Phase 1, 8 Phase 3, 2 Phase 4.
Follow Guillain-Barre Syndrome: new trials by email Literature Review of Guillain-Barre Syndrome trials Research Report on Guillain-Barre Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Empasiprubart as Add-On Therapy to IVIg in Adult Participants With Guillain-Barré Syndrome Empasiprubart IV, Empasiprubart Placebo IV, Intravenous immunoglobulin (IVIg) - Guillain-Barré Syndrome (GBS) | Phase 2 | Not yet recruiting | argenx | 63 | 2026-12-01 | 2026-09-25 |
| Peripheral Nerve Ultrasound in Children With Guillain-Barré Syndrome Guillain-Barre Syndrome | Not yet recruiting | Assiut University | 42 | 2026-10-10 | 2026-10-08 | |
| Myocardial Changes in Pediatric Guillain-Barré Syndrome Myocardial Dysfunction, Guillain-Barre Syndrome | Not yet recruiting | Assiut University | 72 | 2026-09-26 | 2026-09-25 | |
| Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT) Intravenous immunoglobulin (IVIG), Efgartigimod Alfa-Fcab - Guillain-Barré Syndrome | Phase 2 | Not yet recruiting | Beijing Tiantan Hospital | 110 | 2026-09-01 | 2026-09-18 |
| Tongji NADs Cohort No active interventions - Multiple Sclerosis, NMO Spectrum Disorder | Not yet recruiting | Tongji Hospital | 1550 | 2026-03-01 | 2026-01-21 | |
| Effect of PNF + Core Strengthening Exercise in Sub-acute Guillain Barre Syndrome Proprioceptive neuromuscular facilitation combined with core strengthening exercise, conventional physiotherapy - Guillain Barré Syndrome | Not applicable | Completed | Rida | 32 | 2026-02-15 | 2026-08-07 |
| Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome immunosorbent column, intravenous immunoglobulin - Guillain-Barre Syndrome | Not applicable | Not yet recruiting | The First Affiliated Hospital of Zhengzhou University | 204 | 2026-01-01 | 2025-03-12 |
| An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study) Tanruprubart - Guillain-Barre Syndrome | Phase 3 | Recruiting | Annexon, Inc. | 30 | 2025-09-12 | 2026-10-19 |
| The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period. Assistive gait devices combined with physiotherapy - Inclusion Body Myositis, Myotonic Dystrophy 1 | Not applicable | Enrolling by invitation | LMU Klinikum | 30 | 2025-09-01 | 2025-07-18 |
| Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy CIDP - Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome (GBS) | Not yet recruiting | University of Erlangen-Nürnberg Medical School | 30 | 2025-08-06 | 2025-08-14 | |
| Noninvasive Support for Acute Respiratory Failure in Guillain-Barré Syndrome Non-Invasive Ventilation (NIV), High Velocity Nasal Insufflation - Guillain-Barre Syndrome | Not applicable | Recruiting | Assiut University | 80 | 2025-08-01 | 2026-09-22 |
| High-Tech Rehabilitation Pathway for Acute Adult Neuromuscular Diseases - Fit4MedRob-Acute MND Project High-tech rehabilitative treatment, Rehabilitation - Critical Illness Myopathy, Guillain Barré Syndrome | Not applicable | Recruiting | Istituti Clinici Scientifici Maugeri SpA | 124 | 2025-05-28 | 2026-09-21 |
| Living With Guillain-Barré Syndrome as Children. Guillain Barré Syndrome, Guillain-Barré Syndrome (GBS) | Recruiting | University Hospital, Toulouse | 25 | 2025-05-05 | 2026-05-08 | |
| Efgartigimod for the Treatment of Guillain-Barré Syndrome efgartigimod - Guillain-Barre Syndrome (GBS) | Phase 2 / Phase 3 | Not yet recruiting | Zhongming Qiu | 20 | 2025-04-13 | 2025-03-20 |
| Comprehensive Outcomes Monitoring for Peri- and Postnatal Invasive Group B Strep Sequelae (COMPPASS) Registry Invasive Group B Streptococcus Disease, Group B Streptococcus | Not yet recruiting | Precia Group | 10000 | 2025-04-01 | 2025-03-26 | |
| Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature No Interventions - Myositis, Myasthaenia Gravis | Not yet recruiting | Central Hospital, Nancy, France | 5 | 2025-03-01 | 2025-02-18 | |
| Early vs. Late Tracheostomy in Patients With Guillain -Barre Syndrome early tracheostomy (less than 7 days from intubation), Late tracheostomy (more than 7 days from intubation) - Guillain Barre Syndrome, Mechanical Ventilation | Recruiting | Meir Medical Center | 30 | 2025-02-01 | 2026-10-07 | |
| Upper Limb Robot-Assisted Therapy in Patients With Guillain-Barré Syndrome Armeo® Power 2 Exoskeleton - Active Rehabilitation with Feedback and Exercise Gaming, Armeo® Power 2 Exoskeleton - Passive Mobilization without Feedback - Guillain Barré Syndrome | Phase 4 | Active not recruiting | I.R.C.C.S. Fondazione Santa Lucia | 62 | 2024-10-01 | 2026-09-18 |
| Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome Efgartigimod Alfa-Fcab, Intravenous Immunoglobulin (IVIg) - Guillain-Barre Syndrome | Phase 2 | Withdrawn | Chafic Karam | 2024-09-10 | 2026-03-12 | |
| Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders FBIndex - Inclusion Body Myositis, Myotonic Dystrophy | Enrolling by invitation | LMU Klinikum | 108 | 2024-09-09 | 2025-09-10 |
Showing 20 of 95. Sign in to see all of them.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (12) · Multiple Sclerosis (10) · Myasthenia Gravis (10) · Stroke (7) · Disease (6) · Meningitis (5) · Myositis (5) · Amyotrophic Lateral Sclerosis (4) · Autoimmune Diseases of the Nervous System (4) · Neuromyelitis Optica (4) · Arthritis, Rheumatoid (3) · Autoimmune Diseases (3) · Encephalitis (3) · Neuritis (3)
Chronic Disease (95) · Demyelinating Diseases (95) · Disease Attributes (95) · Nervous System Diseases (95) · Pathologic Processes (95) · Pathological Conditions, Signs and Symptoms (95) · Immune System Diseases (94) · Peripheral Nervous System Diseases (94) · Polyneuropathies (94) · Polyradiculoneuropathy (94) · Post-Infectious Disorders (94) · Autoimmune Diseases (92) · Neuromuscular Diseases (92) · Autoimmune Diseases of the Nervous System (91) · Central Nervous System Diseases (17)
Immunoglobulins, Intravenous (8) · Plasmapheresis (3) · Vaccines (3) · Blood Specimen Collection (2) · Physical Therapy Modalities (2) · Plasma Exchange (2) · efgartigimod alfa (2) · 4-Aminopyridine (1) · COVID-19 Vaccines (1) · Data Collection (1) · Fibrinogen (1) · Immunoglobulins (1) · Injections (1) · Mac-1-like protein, Streptococcus (1) · Methylprednisolone (1)
Assiut University (11) · Novartis Vaccines (4) · Annexon, Inc. (3) · Emory University (2) · First Affiliated Hospital of Wenzhou Medical University (2) · Hadassah Medical Organization (2) · LMU Klinikum (2) · Tongji Hospital (2) · University Medical Centre Ljubljana (2) · University of Aarhus (2) · University of Versailles (2) · Aga Khan University (1) · Alexion Pharmaceuticals, Inc. (1) · All Natural Medicine Clinic, LLC (1) · Assistance Publique - Hôpitaux de Paris (1)
United States (16) · France (11) · China (8) · Egypt (8) · Switzerland (6) · Denmark (5) · Germany (5) · United Kingdom (5) · Bangladesh (4) · Japan (4) · Italy (3) · Pakistan (3) · Spain (3) · Argentina (2) · Belgium (2)
Ahmad M. Shaddad, MD (1) · Alda S Marques, PhD (1) · Alex Martino Cinnera, PhD (1) · Aliae A. Hussien, MD (1) · Amira A Sayed Amin, Resident (1) · Aya M Zhran (1) · Azhar A Mohammed Mohammed, Lecturer (1) · Azza A Eltayeb, prof (1) · Bart Jacobs, Dr. (1) · Beatriz Parra, PhD (1) · Bruce Carleton, PharmD (1) · Carlos A Pardo-Villamizar, MD (1)
PMID 16267188, PMID 16271648, PMID 16831974, PMID 16849828, PMID 16900450, PMID 21745374, PMID 22003934, PMID 23568718, PMID 26928074, PMID 27694629, PMID 27705091, PMID 28168524, PMID 28406555, PMID 28975040, PMID 30012780, PMID 30121613, PMID 30679041, PMID 31672665, PMID 32997260, PMID 33828518, PMID 34454432, PMID 34937789, PMID 36809199, PMID 37479377, PMID 37634022, PMID 38987228, PMID 39768590, PMID 41114833, PMID 42592412
2025 (1), R37AI049660 (1)